Skip to content

Insulin glulisine

Apidra (insulin glulisine) is a protein pharmaceutical. Insulin glulisine was first approved as Apidra on 2004-04-16. It has been approved in Europe to treat diabetes mellitus.
Trade Name Apidra
Common Name Insulin glulisine
Indication diabetes mellitus
Drug Class
Insulin glulisine
Get full access now